 develop system lupu erythematosu interferon therapi chronic myelogen leukemia man philadelphia-posit chronic myelogen leukemia interferon-alpha ifn-alpha therapi month system lupu erythematosu diseas featur malar rash migratori arthralgia antinuclear antibodi antin dna hypocomplementemia lymphopenia proteinuria discontinu ifn initi corticosteroid gradual recoveri symptom declin antin dna antinuclear antibodi normal level decreas proteinuria potenti associ ifn therapi develop system lupu erythematosu role ifn autoimmun diseas